CLEVELAND, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Athersys, Inc. (NASDAQ:ATHX) announced today that Gil Van Bokkelen,
Chairman and CEO, will present at the Stifel 2016 Healthcare Conference at the Lotte New York Palace Hotel in New York. The
presentation is scheduled for Wednesday, November 16, 2016 at 3:45 pm ET in the Garrison conference room.
A live audio webcast will be available via the investor relations page of the Athersys website at www.athersys.com. A replay of the presentation will be archived on the Athersys website for
those unable to listen live.
About Athersys
Athersys is an international biotechnology company engaged in the discovery and development of therapeutic
product candidates designed to extend and enhance the quality of human life. The Company is developing its MultiStem®
cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product, initially for disease indications in the
cardiovascular, neurological, inflammatory and immune disease areas, and has several ongoing clinical trials evaluating this
potential regenerative medicine product. Athersys has forged strategic partnerships and collaborations with leading pharmaceutical
and biotechnology companies, as well as world-renowned research institutions to further develop its platform and products. More
information is available at www.athersys.com.
ATHX-G
Contact: William (B.J.) Lehmann, J.D. President and Chief Operating Officer Tel: (216) 431-9900 bjlehmann@athersys.com
